Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
FDA Grants Orphan Drug Designation to NS-051/NCNP-04 for the Treatment of Duchenne Muscular Dystrophy
-
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
-
At Yacht Club de Monaco the 5th Monaco Smart & Sustainable Marina Rendezvous
-
Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation
-
Mark R. DeFazio Honored at Grand Opening of Boro Park JCC Community Center
-
Kraig Biocraft Laboratories Expands Spider Silk Manufacturing with Pursuit of Additional Rearing Center
-
NeoVolta Celebrates RE+2025 Successes & Recaps Announcements
-
Goldmoney Inc. Announces Normal Course Issuer Bid
-
$ASTER TGE Day-One Performance Shines: Exclusive Aster DEX Launch Drives $371 Million Trading Volume and nearly 330,000 New Users
-
Garmin celebrates global innovators and collaborations at 2025 Garmin Health Summit
-
Reshift Media delivers new global website for World Franchise Council
-
SAC Health Announces $10 Million Gift from Yuhaaviatam of San Manuel Nation at Ribbon-Cutting Ceremony to Celebrate New Brier Campus Opening
-
Rocky Shore Gold Announces Upsize of Private Placement
-
WeRide Robobus Receives Belgium's First Level 4 Permit, Leading AV Industry with Products Licensed in Seven Countries
-
Max Stock Announces General Meeting Results
-
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
-
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
-
Pinnacle Fertility Virginia Strengthens Patient Connections with Addition of Bilingual Physician, Dr. Si Won Lee
-
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema
-
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
-
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
-
The Future of Logistics: Technology Meets High-Touch Solutions
-
Emerita Granted Two Additional Properties in the IBW Area, “San Antonio” and “Terranova” Exploration Permits and Enters Into Agreement to Acquire the Nueva Celti Project in Andalusia, Spain
-
Intellum Announces 2025 Growth Makers Awards Winners
-
Canopy Growth Urges Shareholders to Cast their Vote for the Upcoming Annual General and Special Meeting Today
-
Pebblebrook Hotel Trust Announces Exercise In Full of Initial Purchasers' Over-Allotment Option and Subsequent Closing of 1.625% Convertible Senior Notes Due 2030
-
Dentalcorp Declares Dividend and Announces Release Date for Third Quarter 2025 Results
-
Philip Morris International Increases Dividend by 8.9% to Annualized Rate of $5.88 per Share
-
WeRide Robobus Receives Belgium's First Level 4 Permit, Leading AV Industry with Products Licensed in Seven Countries
-
Helium Evolution Announces Management Changes
-
Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia
-
Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks
-
A2Z Cust2Mate Completes Oversubscribed $45 Million Equity Raise, Anchored by Leading Global Financial Institutions
-
Xebra Brands Announces Update on Share Consolidation
-
Samsung, in Collaboration with Niio, Inspires with “Code of Nature” on The Wall LED in Samsung Germany’s Office Lobby
-
Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025
-
CoinEx: User-Centric Approach to Building Trust and Value in the Crypto World
-
Naoris Protocol Showcases Quantum-Resistant Security at 1640 Society Family Office Wealth Forum & Volcano Innovation Summit
-
Naoris Protocol Showcases Quantum-Resistant Security at 1640 Society Family Office Wealth Forum & Volcano Innovation Summit
-
Merck Receives Positive EU CHMP Opinion for ENFLONSIA™ (clesrovimab) for the Prevention of Respiratory Syncytial Virus (RSV) in Infants During Their First RSV Season
-
Dan Herbatschek CEO of Ramsey Theory Group and Tech Entrepreneur Leads Digital Transformation in the Environmental Remediation Industry
-
Merck Receives Two Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab), for Subcutaneous (SC) Administration and for New Indication for Earlier-Stage Head and Neck Cancer
-
Kolibri Global Energy Inc. Announces TSX Approval of Normal Course Issuer Bid
-
Versatrim Launches Commercial Aluminum Moldings for Residential and Commercial Use
-
Weekly Recap: 11 Tech Press Releases You Need to See
-
CANPR Technology Ltd. Announces Director Nominations for Upcoming Shareholder Meeting, Adoption of Advance Notice By-Law
-
Meet Airmoreai Your Everyday Companion for Smart AI Tools Honest Reviews and Useful Free Utilities
-
BizClik Showcases Global Sustainability Leadership at Climate Week NYC 2025
-
First Light Fusion publishes first plausible path to high gain, unlocking cheap fusion energy
-
ATOREST Introduces Dermatologically Tested Bedding for Sensitive Skin
